drugset / Trial / NCT07117474
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and tolerability of a single subcutaneous injection of HRS-9563 in hypertensive subjects
Timeline
- Start
- 2024-12-24
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-9563 | Unknown | — | Subcutaneous |